Theme

Think before you buy

See our new campaign about how to protect yourself when buying medicines – whether at the pharmacy, in retail stores, or online.

Go to theme
Theme

Strategy for the DKMA

The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.

Go to theme
indgangsikon nr 1

General public

Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.

indgangsikon nr 2

Industry

Information on licensing, inspections, fees, company authorisations, clinical trials and more.

indgangsikon nr 3

Healthcare professionals

This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals.

Report a side effect from medicines About Brexit International activities Transparency Subscribe to news in English Mission, vision and strategy Whistleblower scheme New veterinary medicinal products regulation Reporting product defects Inspections Jobs 0

News

Register-based study suggests a slightly increased risk of meningiomas in women using hormonal contraception containing a progestogen

03 July 2026

A study of 25 years of data from Danish women aged 15-59 suggests that meningiomas (tumours of the meninges) may be a very rare side effect of contraceptives containing a progestogen. The Danish Medicines Agency is therefore raising a safety signal in the European Pharmacovigilance Risk Assessment Committee (PRAC).

Are you running clinical trials? You can now activate e-mail notifications in CTIS

29 June 2026

Are you working with cell therapy and planning a clinical trial?

25 June 2026

The guidance on digital and decentralised clinical trials (DCT) has been updated

09 June 2026